Straight From The Cutter's Mouth: A Retina Podcast

Drs. Jeffrey Heier and Peter Kaiser of Ocular Therapeutix join to discuss the SOL-1 trial results investigating a novel tyrosine kinase inhibitor for wet age-related macular degeneration. Conflicts of Interest: Dr. Sridhar has consulted on an advisory board in the past 24 months for Ocular Therapeutix. Dr. Heier and Dr. Kaiser are employed by Ocular Therapeutix.

<p data-rte-preserve-empty="true" style="white-space:pre-wrap;">Drs. Jordan Deaner and Avni Finn join to recap the 2026 Vit-Buckle Society Annual Meeting.</p>

<p data-rte-preserve-empty="true" style="white-space:pre-wrap;">Dr. Kristen Nwanyanwu joins the program to discuss her research into diabetic retinopathy screening and treatment disparities in the United States and other research related topics.</p>

<p data-rte-preserve-empty="true" style="white-space:pre-wrap;">Drs. Mohsin Ali and Akshay Thomas join to preview the May 2026 edition of Retinal Physician found online at <a href="http://www.retinalphysician.com">http://www.retinalphysician.com</a><a href="http://www.retinalphysician.com/">. Discussion includes managemen</a>t options for diabetic retinopathy and diabetic macular edema, artificial intelligence screening for diabetic retinopathy, and the PRIMA subretinal implant.&nbsp;</p>